TMCnet News
Heartlab's CardioNow Expands Installation Base to Include Leading European Cardiology Contract Research Organization; Cardialysis B.V. deploys Heartlab's CardioNow internet-based image management solution for cardiovascular clinical trials.WESTERLY, R.I. --(Business Wire)-- May 4, 2005 -- Heartlab, the world's leading designer and supplier of digital image and information networks for cardiology, today announced the installation of Heartlab's CardioNow telecardiology and image management solution for cardiovascular drug and device studies at Cardialysis B.V., a leading cardiology contract research organization based in Rotterdam, The Netherlands. Heartlab's web-based CardioNow technology enables easy electronic sharing of patient angiograms and ultrasound studies required by cardiovascular device and drug clinical trials. Within minutes of patient enrollment, complete DICOM studies can be transferred from investigator sites to angiographic and ultrasound core labs anywhere in the world for analysis. Additionally, these studies can be made available online for simultaneous review by other stakeholders such as clinical event committee members, safety monitoring board members and trial sponsors. Cardialysis B.V. will now be able to offer its clients CardioNow's streamlined web-based solution to handle receipt, tracking, archiving, and analysis of complex cardiac images from hospital investigator sites around the world. This installation represents the seventh cardiovascular core lab to endorse Heartlab's CardioNow web-based solution for clinical trial image management. "Heartlab's CardioNow replaces the traditional mail-based and manual tracking and archiving method of managing patient films for clinical trails. The old method delayed database lock and added weeks or months onto the duration of a trial," commented Heartlab CEO Robert Petrocelli. "Heartlab's CardioNow eliminates these costly delays by enabling core labs and other stakeholders to receive and analyze these critically important images with minutes of initial patient enrollment. Prompt study analysis reduces product development times and expedites speed to market for new cardiovascular devices and drugs. We are excited that our innovative solution for clinical trial image management is now available at Cardialysis B.V., one of the world's leading cardiovascular contract research organizations." Additional information on Heartlab's CardioNow image management solution for clinical trials can be obtained at http://www.heartlab.com/cardionow.htm. About Heartlab Heartlab is the world's leading designer and supplier of digital image and information networks for cardiology. Named one of America's fastest-growing private companies for four years in a row by Inc. magazine, Heartlab's Encompass networks are installed in more than 250 of the nation's leading heart centers, giving cardiologists rapid access to imaging exam and report information and providing robust protection for critical patient data. The company's CardioNow image management solution for clinical trials is used by leading cardiovascular core labs and cardiovascular device and drug companies to expedite the sharing, tracking and analysis of complex cardiac images for over 30 multi-center clinical trails including vulnerable plaque, drug-eluting stent, bare metal stent, and distal protection device studies. For more information, visit www.Heartlab.com. About Cardialysis B.V. Cardialysis B.V. is an independent Contract Research Organization (CRO) specialized in Cardiology. Since its inception in 1984, Cardialysis has gained extensive experience in the central coordination and logistics of clinical research projects, including phase II, III and IV studies of novel drugs, as well as new medical devices. Based in The Netherlands, Cardialysis has a network of over 1200 cardiology sites world-wide, including more than 800 in Europe. These sites offer high quality data and are experienced in working according to GCP standards and Cardialysis Standard Operating Procedures (SOPs). Having established this network, Cardialysis is able to reduce the time for site selection to a minimum without compromising on the quality and patient volume of participating sites. On top of that, the highly motivated and well-known investigators ensure the shortest possible patient enrollment. For additional information visit www.Cardialysis.com. |
